BamlanivimabEmergency Use Authorization (EUA) for the Treatment of COVID-19 EUA for the Treatment of COVID-19BamlanivimabAdministrationHealthcare ProvidersSafety InformationLimitations of Authorized UseImportant Safety InformationHypersensitivity Including Anaphylaxis and Infusion-Related ReactionsLimitations of Benefit and Potential Risk in Patients with Severe COVID-19Adverse EventsUse in Specific Populations
